Phenotype
|
Fish
|
Conditions
|
Figures
|
eye photoreceptor cell alignment eye photoreceptor cell, abnormal
|
llgl2to6/to6 + MO1-llgl2
|
standard conditions
|
Fig. 5
from Kujawski et al., 2019
|
retinal outer nuclear layer morphology, abnormal
|
llgl2to6/to6 + MO1-llgl2
|
standard conditions
|
Fig. 5
from Kujawski et al., 2019
|
retina morphology, abnormal
|
llgl2to6/to6 + MO1-llgl2
|
standard conditions
|
Fig. 6
from Kujawski et al., 2019
|
eye photoreceptor cell mislocalised, abnormal
|
llgl2to6/to6 + MO1-llgl2
|
standard conditions
|
Fig. 6
from Kujawski et al., 2019
|
retinal photoreceptor layer disorganized, abnormal
|
llgl2to6/to6 + MO1-llgl2
|
standard conditions
|
Fig. 7
from Kujawski et al., 2019
|
retinal inner nuclear layer cell mislocalised, abnormal
|
llgl2to6/to6 + MO1-llgl2
|
standard conditions
|
Fig. 6
from Kujawski et al., 2019
|
retinal photoreceptor layer morphology, abnormal
|
llgl2to6/to6 + MO1-llgl2
|
standard conditions
|
Fig. 5 ,
Fig. 6
from Kujawski et al., 2019
|
outer limiting membrane morphology, abnormal
|
llgl2to6/to6 + MO1-llgl2
|
standard conditions
|
Fig. 7
from Kujawski et al., 2019
|
retinal inner nuclear layer morphology, abnormal
|
llgl2to6/to6 + MO1-llgl2
|
standard conditions
|
Fig. 6
from Kujawski et al., 2019
|
left/right pattern formation disrupted, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 7
from Ji et al., 2016
|
Kupffer's vesicle decreased volume, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
otic vesicle has fewer parts of type otic vesicle motile cilium, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
brain right side elovl6 expression mislocalised, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 7
from Ji et al., 2016
|
pronephric duct motile cilium disorganized, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
Kupffer's vesicle motile cilium assembly decreased process quality, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
pronephric duct morphogenesis decreased process quality, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
brain hydrocephalic, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
otic vesicle motile cilium decreased length, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
Kupffer's vesicle has fewer parts of type Kupffer's vesicle motile cilium, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
brain elovl6 expression spatial pattern, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 7
from Ji et al., 2016
|
otic vesicle decreased volume, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
otic vesicle motile cilium assembly decreased process quality, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
Kupffer's vesicle development decreased process quality, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
determination of left/right asymmetry in nervous system disrupted, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 7
from Ji et al., 2016
|
determination of heart left/right asymmetry decreased process quality, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 3
from Tay et al., 2013
|
Kupffer's vesicle motile cilium decreased length, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
pronephric duct motile cilium decreased length, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
lateral plate mesoderm bilateral symmetry, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 3
from Tay et al., 2013
|
post-vent region curved ventral, abnormal
|
AB/TU + MO1-llgl2
|
standard conditions
|
Fig. 1
from Tay et al., 2013
|
eye photoreceptor cell alignment eye photoreceptor cell, abnormal
|
llgl2to6/+ + MO1-llgl2
|
standard conditions
|
Fig. 5
from Kujawski et al., 2019
|
retinal outer nuclear layer morphology, abnormal
|
llgl2to6/+ + MO1-llgl2
|
standard conditions
|
Fig. 5
from Kujawski et al., 2019
|
retinal photoreceptor layer morphology, abnormal
|
llgl2to6/+ + MO1-llgl2
|
standard conditions
|
Fig. 5
from Kujawski et al., 2019
|
Kupffer's vesicle basolateral plasma membrane physical object quality, abnormal
|
pt19Tg + MO1-llgl2
|
standard conditions
|
Fig. 4
from Tay et al., 2013
|
Kupffer's vesicle motile cilium decreased length, abnormal
|
s870Tg + MO1-llgl2
|
standard conditions
|
Fig. 2
from Tay et al., 2013
|
Kupffer's vesicle has fewer parts of type Kupffer's vesicle motile cilium, abnormal
|
s870Tg + MO1-llgl2
|
standard conditions
|
Fig. 2
from Tay et al., 2013
|
Kupffer's vesicle decreased area, abnormal
|
s870Tg + MO1-llgl2
|
standard conditions
|
Fig. 2
from Tay et al., 2013
|
heart looping decreased process quality, abnormal
|
twu34Tg + MO1-llgl2
|
standard conditions
|
Fig. 3
from Tay et al., 2013
|
heart symmetry, abnormal
|
twu34Tg + MO1-llgl2
|
standard conditions
|
Fig. 3
from Tay et al., 2013
|
Kupffer's vesicle anatomical space decreased volume, abnormal
|
a131Tg; sny120Tg + MO1-llgl2 + MO4-tp53
|
chemical treatment by environment: afimoxifene
|
Fig. 6
from Dasgupta et al., 2018
|
ventral fin fold malformed, abnormal
|
AB + MO1-llgl2 + MO2-clint1a
|
standard conditions
|
Fig. 6
from Dodd et al., 2009
|
epidermis malformed, abnormal
|
AB + MO1-llgl2 + MO2-clint1a
|
standard conditions
|
Fig. 6
from Dodd et al., 2009
|
keratinocyte ab5-akt labeling amount, ameliorated
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic, chemical treatment by environment: LY294002
|
Fig 7
from Hatzold et al., 2023
|
epidermis potentially cancerous lesions amount, ameliorated
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic, chemical treatment by environment: sirolimus
|
Fig 7
from Hatzold et al., 2023
|
keratinocyte ab5-akt labeling spatial pattern, abnormal
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic
|
Fig 7
from Hatzold et al., 2023
|
keratinocyte ab5-akt labeling spatial pattern, ameliorated
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic, chemical treatment by environment: LY294002
|
Fig 7
from Hatzold et al., 2023
|
epidermis potentially cancerous lesions amount, ameliorated
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic, chemical treatment by environment: wortmannin
|
Fig 7
from Hatzold et al., 2023
|
epidermis mmp9 expression amount, ameliorated
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic, chemical treatment by environment: sirolimus
|
Fig 7
from Hatzold et al., 2023
|
epidermis mmp9 expression amount, ameliorated
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic, chemical treatment by environment: LY294002
|
Fig 7
from Hatzold et al., 2023
|
epidermis potentially cancerous lesions increased amount, exacerbated
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic
|
Fig 7
from Hatzold et al., 2023
|
epidermis potentially cancerous lesions amount, ameliorated
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic, chemical treatment by environment: LY294002
|
Fig 7
from Hatzold et al., 2023
|
keratinocyte ab5-akt labeling increased amount, abnormal
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic
|
Fig 7
from Hatzold et al., 2023
|
epidermis mmp9 expression increased amount, abnormal
|
AB + MO1-llgl2 + MO6-pax2a
|
hypotonic
|
Fig 7
from Hatzold et al., 2023
|
epidermis morphology, abnormal
|
WT + MO1-llgl2 + MO2-atp1b1a
|
standard conditions
|
Fig. 7
from Hatzold et al., 2016
|
epidermal cell aggregated, abnormal
|
WT + MO1-llgl2 + MO2-atp1b1a
|
standard conditions
|
Fig. 7
from Hatzold et al., 2016
|
Kupffer's vesicle basolateral plasma membrane physical object quality, abnormal
|
pt19Tg + MO1-llgl2 + MO1-rab11a
|
standard conditions
|
Fig. 6
from Tay et al., 2013
|
Kupffer's vesicle development decreased process quality, abnormal
|
s870Tg + MO1-llgl2 + MO1-rab11a
|
standard conditions
|
Fig. 5
from Tay et al., 2013
|
Kupffer's vesicle decreased volume, abnormal
|
s870Tg + MO1-llgl2 + MO1-rab11a
|
standard conditions
|
Fig. 5
from Tay et al., 2013
|